Thomas Dyrberg

Thomas Dyrberg is a prominent figure in the life sciences investment sector, currently serving as a Partner at Novo Holdings, a leading global investor in this field. He joined Novo Holdings in 2000 and has played a significant role in establishing and developing Novo Ventures, the company's venture capital arm. Dyrberg has held various key positions, including Senior Partner and Managing Partner, where he has been instrumental in driving the firm's growth and reputation within the biotech investment community.123

Professional Background

• Experience: Dyrberg has extensive experience in strategic planning, financial management, and business development. His leadership has helped Novo Ventures rank among the top biotech venture investors globally.1
• Board Memberships: He serves on the boards of several companies, including Allievex Inc. and Anokion SA, further showcasing his influence in the life sciences sector.24
• Previous Roles: Before his current role, he held research positions at the Hagedorn Institute, contributing to his deep understanding of the life sciences industry.2

Education and Skills

Dyrberg's educational background and specific qualifications are not detailed in the provided sources, but his skill set includes:

• Strategic investment planning
• Financial analysis
• Business development within life sciences

Dyrberg's contributions have been recognized for aligning with Novo Holdings' mission to deliver performance with respect and responsibility in its investments.1